LN Peptides
Finnrick has tested 28 samples from LN Peptides across 5 products.
Finnrick Vendor Profile
to
LN Peptides
Tracking 5 products
28 total samples tested
Last test 2 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 7 | 17 Nov 2025 | 20 Feb 2026 | |||||
| Tirzepatide | 13 | 3 Oct 2025 | 20 Feb 2026 | |||||
| Tesamorelin | 6 | 21 Oct 2025 | 2 Mar 2026 | |||||
| Mazdutide | 1 | 9 Oct 2025 | 9 Oct 2025 | |||||
| Ipamorelin | 1 | 25 Sep 2025 | 25 Sep 2025 | |||||
The LN Peptides samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.0
Based on 4 overall satisfaction reports
Ease of Purchase4.3(4)
Payment Methods4.3(4)
Delivery Speed4.0(4)
Packaging Quality4.3(4)
Customer Service4.3(4)
People who submitted test requests to Finnrick gave LN Peptides an average satisfaction rating of 4.0 out of 5 across 4 reports associated with samples received and tested by Finnrick.
Most recent LN Peptides tests
Samples are tested in commercial labs
28
tests
5
products
Scores
AVGMINMAX
First
25 Sept 2025
Last
2 Mar 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 2 Mar 2026 | Tesamorelin | View | 10mg | 10.3mg | +3.0% | 98.47% | below LOQ | TES10012026LN | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 26 Feb 2026 | Tesamorelin | View | 20mg | 22.8mg | +14.0% | 98.88% | n/a | (no batch ID) | No Label / Silver Crimp / Clear Pink Cap | Lab E | Public | |
| 26 Feb 2026 | Tesamorelin | View | 10mg | 11.5mg | +15.0% | 99.72% | n/a | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 20 Feb 2026 | Retatrutide | View | 10mg | 11.3mg | +13.0% | 99.70% | n/a | (no batch ID) | White Label / Silver Crimp / White Cap | Lab G | Public | |
| 20 Feb 2026 | Tirzepatide | View | 40mg | 35.2mg | -12.0% | 99.73% | n/a | (no batch ID) | Teal Label / Silver Crimp / White Cap | Lab E | Public | |
| 18 Feb 2026 | Tirzepatide | View | 100mg | 88.5mg | -11.5% | 99.80% | n/a | FF-VP1225LN | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 15 Feb 2026 | Retatrutide | View | 30mg | 30mg | 99.80% | n/a | (no batch ID) | No Label / Silver Crimp / Clear Pink Cap | Lab G | Public | ||
Corrections
- 12 Dec 2025:
- Submitter originally registered vendor as "Diju Peptides Wellness" by mistake during sample registration, the test result has been adjusted to to "LN Peptides".
- 12 Dec 2025:
- Submitter originally registered vendor as "Diju Peptides Wellness" by mistake during sample registration, the test result has been adjusted to to "LN Peptides".